Disclosed is the compound N-[4-chloro-2-hydroxy-3-(piperazine-1-sulfonyl)phenyl]-N'-(2- chloro-3-fluorophenyl)urea, p-toluenesulfonic acid salt, a pharmaceutical composition comprising said compound and its use for treating chemokine mediated disease, asthma, chronic obstructive pulmonary disease (COPD) or adult respiratory distress syndrome. Also disclosed is a method of preparing said compound.
申请公布号
NZ573733(A)
申请公布日期
2011.03.31
申请号
NZ20070573733
申请日期
2007.06.22
申请人
SMITHKLINE BEECHAM CORPORATION
发明人
BUSCH-PETERSEN, JAKOB;BROOK, CHRISTOPHER, S;GOODMAN, RICHARD, M;WEBB, EDWARD, C